[Lipoprotein(a): a link between thrombosis and atherosclerosis?]

Area of Science:

• Biochemistry
• Genetics
• Cardiovascular Medicine

Context:

• Lipoprotein(a) (Lp(a)) is structurally similar to LDL but includes apolipoprotein(a) (apo(a)) with homology to plasminogen.
• Plasma Lp(a) levels are inherited as a quantitative genetic trait with a wide distribution in Caucasian populations.
• Elevated Lp(a) levels are associated with an increased risk of atherosclerotic disease.

Purpose:

• To investigate the unknown physiological role and obscure metabolism of Lp(a).
• To explore the prothrombotic and proatherogenic potential of Lp(a) suggested by its structural similarity to plasminogen.
• To address the limited understanding of Lp(a)'s exact pathophysiological mechanisms in disease.

Summary:

• Lp(a) is a lipoprotein with a genetic basis, associated with higher atherosclerotic disease risk.
• Its physiological function and metabolic pathways are not well understood.
• Lp(a) appears resistant to conventional diets and drug therapies; LDL-apheresis is effective for reduction but clinical benefits are unproven.

Impact:

• Highlights the need for further research into Lp(a)'s function and metabolism.
• Suggests potential therapeutic targets related to Lp(a)'s prothrombotic and proatherogenic properties.
• Underscores the current lack of established therapeutic goals for managing Lp(a) levels despite its association with cardiovascular risk.